Research and Development

Showing 15 posts of 9607 posts found.

Yale-backed study to test efficacy of AI-selected therapy in COVID-19

July 28, 2020 Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …
shutterstock_159488225

Farxiga smashes all goals in Phase 3 chronic kidney disease trial, says AstraZeneca

July 28, 2020 Manufacturing and Production, Research and Development AstraZeneca, farxiga

AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the …
shutterstock_273326141

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020 Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
moderna_norwood_plant

US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine

July 27, 2020 Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020 Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020 Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
shutterstock_244903099

UK Government invests £100m in new COVID-19 vaccine manufacturing site

July 23, 2020 Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
winter_mask

Research suggests COVID-19 outcomes are worse in colder months

July 23, 2020 Research and Development COVID-19, coronavirus

A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020 Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
fda

FDA sets out guidelines on cannabis derived drugs

July 22, 2020 Research and Development CBD, CBD Oil

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …
abbvie_0

AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits

July 22, 2020 Research and Development AbbVie, atopic dermatits, pharma, upadacitinib

AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …
vaccinessssssssssssssssssss_1

US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research

July 22, 2020 Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines

Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 22, 2020 Research and Development COVID-19, coronavirus

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
The Gateway to Local Adoption Series

Latest content